TABLE 1. PATENTS REGISTERED/APPROVED IN THE WORLD, 2011-2017
TABLE 2. GLOBAL GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 3. LIST OF BRAND NAMES OF METOCLOPRAMIDE ACROSS THE WORLD
TABLE 4. GASTROPARESIS DRUGS MARKET FOR PROKINETIC AGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GASTROPARESIS DRUGS MARKET FOR ANTIEMETIC AGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GASTROPARESIS DRUGS MARKET FOR BOTULINUM TOXIN INJECTIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 8. GASTROPARESIS DRUGS MARKET FOR DIABETIC GASTROPARESIS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GASTROPARESIS DRUGS MARKET FOR IDIOPATHIC GASTROPARESIS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GASTROPARESIS DRUGS MARKET FOR POST-SURGICAL GASTROPARESIS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GASTROPARESIS DRUGS MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 13. GASTROPARESIS DRUGS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GASTROPARESIS DRUGS MARKET FOR PHARMACIES, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GASTROPARESIS DRUGS MARKET FOR CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GASTROPARESIS DRUGS MARKET FOR E-COMMERCE, BY REGION, 2016-2023 ($MILLION)
TABLE 17. TOP 10 COUNTRIES WITH DIABETES INCIDENCE (20-79 YEARS), 2015 AND 2040
TABLE 18. GASTROPARESIS DRUGS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA GASTROPARESIS DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. U.S. GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 21. U.S. GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 22. U.S. GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 23. CANADA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 24. CANADA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 25. CANADA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 26. MEXICO GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 27. MEXICO GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 28. MEXICO GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 32. EUROPE GASTROPARESIS DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. GERMANY GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 34. GERMANY GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 35. GERMANY GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 36. FRANCE GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 37. FRANCE GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 38. FRANCE GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 39. UK GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 40. UK GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 41. UK GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 42. ITALY GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 43. ITALY GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 44. ITALY GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 45. SPAIN GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 46. SPAIN GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 47. SPAIN GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 48. REST OF EUROPE GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 49. REST OF EUROPE GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 50. REST OF EUROPE GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 51. EUROPE GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 52. EUROPE GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 53. EUROPE GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 54. ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 55. JAPAN GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 56. JAPAN GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 57. JAPAN GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 58. CHINA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 59. CHINA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 60. CHINA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 61. AUSTRALIA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 62. AUSTRALIA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 63. AUSTRALIA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 64. INDIA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 65. INDIA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 66. INDIA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 67. SOUTH KOREA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 68. SOUTH KOREA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 69. SOUTH KOREA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 73. ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 74. ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 75. ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 76. LAMEA GASTROPARESIS DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 77. BRAZIL GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 78. BRAZIL GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 79. BRAZIL GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 80. SAUDI ARABIA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 81. SAUDI ARABIA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 82. SAUDI ARABIA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 83. SOUTH AFRICA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 84. SOUTH AFRICA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 85. SOUTH AFRICA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 86. REST OF LAMEA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 87. REST OF LAMEA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 88. REST OF LAMEA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 89. LAMEA GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($MILLION)
TABLE 90. LAMEA GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023 ($MILLION)
TABLE 91. LAMEA GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 92. ABBOTT: COMPANY SNAPSHOT
TABLE 93. ABBOTT: OPERATING SEGMENTS
TABLE 94. ABBOTT: PRODUCT PORTFOLIO
TABLE 95. ALLERGAN: COMPANY SNAPSHOT
TABLE 96. ALLERGEN: OPERATING SEGMENTS
TABLE 97. ALLERGAN: PRODUCT PORTFOLIO
TABLE 98. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 99. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 100. CADILA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 101. CADILA PHARMACEUTICALS: DIVISIONS
TABLE 102. CADILA PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 103. ETX PHARMA: COMPANY SNAPSHOT
TABLE 104. ETX PHARMA: PRODUCT PORTFOLIO
TABLE 105. EVOKE: COMPANY SNAPSHOT
TABLE 106. EVOKE: PRODUCT PORTFOLIO
TABLE 107. GSK: COMPANY SNAPSHOT
TABLE 108. GSK: OPERATING SEGMENTS
TABLE 109. GSK: PRODUCT PORTFOLIO
TABLE 110. NEUROGASTRX: COMPANY SNAPSHOT
TABLE 111. NEUROGASTRX: PRODUCT PORTFOLIO
TABLE 112. THERAVANCE BIOPHARMA: COMPANY SNAPSHOT
TABLE 113. THERAVANCE BIOPHARMA: PRODUCT PORTFOLIO
TABLE 114. VALEANT: COMPANY SNAPSHOT
TABLE 115. VALEANT: OPERATING SEGMENTS
TABLE 116. VALEANT: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. GLOBAL GASTROPARESIS DRUGS MARKET, 2016-2023
FIGURE 2. GASTROPARESIS DRUGS MARKET SEGMENTATION
FIGURE 3. TOP INVESTMENT POCKETS
FIGURE 4. TOP PLAYER POSITIONING, 2016
FIGURE 5. TRANSPLANTATION PERFORMED IN 2015 IN U.S.
FIGURE 6. UNDIAGNOSED PATIENT POPULATION OF DIABETES, 2015 (MILLION)
FIGURE 7. WORLD POPULATION AGED 65 AND OVER: 2015, 2030, AND 2050 (IN MILLION)
FIGURE 8. IMPACT ANALYSIS, 2016
FIGURE 9. GASTROPARESIS DRUGS MARKET: CLINICAL TRIALS
FIGURE 10. PATENTS ANALYSIS BY YEAR (2011-2017)
FIGURE 11. GLOBAL GASTROPARESIS DRUGS MARKET, BY DRUG CLASS, 2016-2023
FIGURE 12. GLOBAL GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE, 2016-2023
FIGURE 13. GLOBAL GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023
FIGURE 14. NORTH AMERICA GASTROPARESIS DRUGS MARKET, 2016-2023
FIGURE 15. TOTAL NUMBER OF TRANSPLANTS PERFORMED IN U.S., 2017
FIGURE 16. EUROPE GASTROPARESIS DRUGS MARKET, 2016-2023
FIGURE 17. PREVALENCE OF DIABETES IN EUROPEAN COUNTRIES IN ADULTS AGED 20-79 YEARS, 2010 (%)
FIGURE 18. ASIA-PACIFIC GASTROPARESIS DRUGS MARKET, 2016-2023
FIGURE 19. ANNUAL TRENDS IN LIVER TRANSPLANTS IN INDIA, 2013
FIGURE 20. LAMEA GASTROPARESIS DRUGS MARKET, 2016-2023
FIGURE 21. ESTIMATED NUMBER OF PEOPLE WITH DIABETES IN BRAZIL, 2013 VS. 2035 (MILLION)
FIGURE 22. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 23. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 24. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 25. ALLERGAN: NET SALES, 2014-2016 ($MILLION)
FIGURE 26. ALLERGAN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 27. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 28. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 29. GSK: REVENUE, 2014-2016 ($MILLION)
FIGURE 30. GSK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 31. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 32. THERAVANCE BIOPHARMA: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. THERAVANCE BIOPHARMA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. VALEANT: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. VALEANT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 36. VALEANT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)